Cargando…
A CD44-specific peptide, RP-1, exhibits capacities of assisting diagnosis and predicting prognosis of gastric cancer
Early diagnosis and evaluation of prognosis are both crucial for preventing poor prognosis of patients with gastric cancer (GC), a leading cause of cancer-related deaths worldwide. Cluster of differentiation 44 (CD44), an indicator of cancer stem cells, can be specifically targeted by molecular prob...
Autores principales: | Li, Weiming, Jia, Huan, Wang, Jichang, Guan, Hao, Li, Yan, Zhang, Dan, Tang, Yanan, Wang, Thomas D., Lu, Shaoying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444726/ https://www.ncbi.nlm.nih.gov/pubmed/28415792 http://dx.doi.org/10.18632/oncotarget.16275 |
Ejemplares similares
-
MicroRNA-93 promotes proliferation and metastasis of gastric cancer via targeting TIMP2
por: Guan, Hao, et al.
Publicado: (2017) -
Screening and identification of a CD44v6 specific peptide using improved phage display for gastric cancer targeting
por: Zhang, Dan, et al.
Publicado: (2020) -
Human epithelial ovarian cancer cells expressing CD105, CD44 and CD106 surface markers exhibit increased invasive capacity and drug resistance
por: Zhang, Jin, et al.
Publicado: (2019) -
Azelnidipine Exhibits In Vitro and In Vivo Antiviral Effects against Flavivirus Infections by Targeting the Viral RdRp
por: Wang, Zhuang, et al.
Publicado: (2022) -
The Role of CD44 in the Pathogenesis, Diagnosis, and Therapy of Gastric Cancer
por: Jang, Byung Ik, et al.
Publicado: (2011)